DBD
CTCP Dược - Trang thiết bị Y tế Bình Định (Bidiphar) · HOSE
52,000
Slightly negative · Working capital 218 days
On a TTM 2026Q1 basis, DBD is maintaining revenue, but margins are compressing slightly — profit is at an all-time high. What remains unclear is whether this is a short-term fluctuation or costs are starting to outpace revenue.
Revenue TTM
VND 1,872bn
+4.9%
Net Margin
15.49%
−0.7pp year on year
ROE
16.3%
TTM
Related News